Skip to main content
main-content

01.12.2012 | Primary research | Ausgabe 1/2012 Open Access

Cancer Cell International 1/2012

Investigation of the apoptotic way induced by digallic acid in human lymphoblastoid TK6 cells

Zeitschrift:
Cancer Cell International > Ausgabe 1/2012
Autoren:
Wissem Bhouri, Jihed Boubaker, Ines Skandrani, Kamel Ghedira, Leila Chekir Ghedira
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1475-2867-12-26) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

BW: Was responsible for the conception and design, testing and data acquisition, analysis and data interpretation and drafted the manuscript. BJ: made contribution to the study of caspase activities. SI: made contribution to cell culture and the study of the cytotoxicity and the DNA fragmentation. GK: made substantial contribution to conception and revised it critically for Important intellectual content. CGL:made substantial contribution to conception and revised it critically for important intellectual content. All authors read and approved the final manuscript.

Abstract

Background

The digallic acid (DGA) purified from Pistacia lentiscus. L fruits was investigated for its antiproliferative and apoptotic activities on human lymphoblastoid TK6 cells.

Methods

We attempt to characterize the apoptotic pathway activated by DGA. Apoptosis was detected by DNA fragmentation, PARP cleavage and by evaluating caspase activities.

Results

The inhibition of lymphoblastoid cell proliferation was noted from 8.5 μg/ml of DGA. The induction of apoptosis was confirmed by DNA fragmentation and PARP cleavage. We have demonstrated that DGA induces apoptosis by activating the caspase-8 extrinsic pathway. Caspase-3 was also activated in a dose dependent manner.

Conclusion

In summary, DGA exhibited an apoptosis inductor effect in TK6 cells revealing thus its potential as a cancer-preventive agent.
Zusatzmaterial
Authors’ original file for figure 1
12935_2011_353_MOESM1_ESM.gif
Authors’ original file for figure 2
12935_2011_353_MOESM2_ESM.gif
Authors’ original file for figure 3
12935_2011_353_MOESM3_ESM.gif
Authors’ original file for figure 4
12935_2011_353_MOESM4_ESM.gif
Authors’ original file for figure 5
12935_2011_353_MOESM5_ESM.gif
Authors’ original file for figure 6
12935_2011_353_MOESM6_ESM.gif
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

Cancer Cell International 1/2012 Zur Ausgabe